Updates and news related to prostate cancer:
Ongoing challenges for the treatment of patients with oligometastatic disease
Approximately half of prostate cancer patients with clinically actionable gene variants do not meet the NCCN guideline criteria for genetic testing, according to findings from the PROCLAIM trial.
Use of non-contrast MRI also showed the potential to decrease identification of clinically insignificant disease.
Data showed a significant association between the biomarkers and prostate cancer in Black men, but the association was not found to be significant among White men.
High-volume radiation treatment facilities contribute to better survival outcomes in men with very high-risk prostate cancer compared with low-volume centers, a new study suggests.
This modality may obviate performing multiple imaging sessions and high-cost scans in patients diagnosed with the high-burden disease.
Findings may help clinicians and patients take the next step in care of traditionally elevated PSA level.
Partaking in resistance and aerobic exercise was found to improve erectile function and intercourse satisfaction among men receiving treatment for prostate cancer.
A molecular imaging tool helps improve the accuracy of predicting the risk of cancer recurrence in patients with intermediate to high-risk prostate cancer who undergo surgery.
The PET radiotracer 18F-PSMA-1007 facilitated detection of at least one suspicious lesion for metastasis in nearly half of a cohort of 160 patients with prostate cancer, according to a recent study.